Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Schlechter

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
BMC Cancer|March 8, 2008
CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancerPamela S Larson, Benjamin L Schlechter, Chia-Lin King, et al.
Blood Advances|May 23, 2020
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trialJeffrey I Zwicker, Joanna Roopkumar, Maneka Puligandla, et al.
Investigational New Drugs|March 5, 2024
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancerAndrew H Ko, Andrew L Coveler, Benjamin L Schlechter, et al.
Biomedical Microdevices|July 29, 2016
Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endotheliumAbhishek Jain, Andries D van der Meer, Anne-Laure Papa, et al.
JCI Insight|January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancerJeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2026
Autologous T Cell Antigen Coupler Targeting HER2 (TAC01-HER2) in Advanced or Metastatic Solid TumorsEcaterina E Dumbrava, Daniel Olson, Mohamed A Gouda, et al.
JAMA Network Open|January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical TrialBrandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET)Kimberly J Perez, Nora Horick, Joanna Baginska, et al.
Cancer Immunology Research|September 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal CancerBrandon M Huffman, Osama E Rahma, Kevin Tyan, et al.
JCO Precision Oncology|June 21, 2023
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI CancerHarshabad Singh, Samuel J Klempner, Nelya Melnitchouk, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
BMC Cancer|March 8, 2008
CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancerPamela S Larson, Benjamin L Schlechter, Chia-Lin King, et al.
Blood Advances|May 23, 2020
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trialJeffrey I Zwicker, Joanna Roopkumar, Maneka Puligandla, et al.
Investigational New Drugs|March 5, 2024
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancerAndrew H Ko, Andrew L Coveler, Benjamin L Schlechter, et al.
Biomedical Microdevices|July 29, 2016
Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endotheliumAbhishek Jain, Andries D van der Meer, Anne-Laure Papa, et al.
JCI Insight|January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancerJeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2026
Autologous T Cell Antigen Coupler Targeting HER2 (TAC01-HER2) in Advanced or Metastatic Solid TumorsEcaterina E Dumbrava, Daniel Olson, Mohamed A Gouda, et al.
JAMA Network Open|January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical TrialBrandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET)Kimberly J Perez, Nora Horick, Joanna Baginska, et al.
Cancer Immunology Research|September 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal CancerBrandon M Huffman, Osama E Rahma, Kevin Tyan, et al.
JCO Precision Oncology|June 21, 2023
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI CancerHarshabad Singh, Samuel J Klempner, Nelya Melnitchouk, et al.
Pageof 3